Excellent - I now have comprehensive data from Robbins Pathology, Bailey & Love, Grainger & Allison, and Sabiston. Let me compile a thorough, well-structured response.
Bone Tumours - Comprehensive Guide
Sources: Robbins & Kumar Basic Pathology; Grainger & Allison's Diagnostic Radiology; Bailey and Love's Short Practice of Surgery 28th Ed; Sabiston Textbook of Surgery; Campbell's Operative Orthopaedics 15th Ed 2026
1. Definition & Overview
A bone tumour is an abnormal proliferation of cells within bone tissue. They are classified according to the normal cell type they recapitulate or the matrix they produce (Robbins Pathology). The WHO 2013 classification divides them into benign, intermediate, and malignant categories:
- Benign - slow-growing, well-defined, no metastatic potential
- Intermediate - locally aggressive or rarely metastasize (e.g., Giant Cell Tumour)
- Malignant - invasive, destructive, high metastatic potential
Benign tumours greatly outnumber malignant tumours and peak in the first three decades of life. In older adults, a bone tumour is more likely to be malignant. - Robbins & Kumar Basic Pathology
2. WHO Classification Chart
| Category | Behaviour | Tumour Type | Common Location | Age (yr) |
|---|
| Cartilage-forming | Benign | Osteochondroma | Metaphysis, long bones | 10-30 |
| Benign | Enchondroma (Chondroma) | Small bones of hands/feet | 30-50 |
| Malignant | Chondrosarcoma | Pelvis, shoulder | 40-60 |
| Bone-forming | Benign | Osteoid Osteoma | Metaphysis, femur/tibia cortex | 10-20 |
| Benign | Osteoblastoma | Vertebral column | 10-20 |
| Malignant | Osteosarcoma | Metaphysis near knee | 10-20 (bimodal) |
| Fibrous tissue | Benign/Intermediate | Non-ossifying fibroma | Long bone metaphysis | 10-20 |
| Malignant | Fibrosarcoma | Long bones | 30-60 |
| Haematopoietic | Malignant | Multiple Myeloma | Axial skeleton, vertebrae | >60 |
| Malignant | Lymphoma | Variable | Variable |
| Vascular | Benign | Haemangioma | Vertebral body | Any age |
| Malignant | Angiosarcoma | Long bones | Variable |
| Unknown origin | Malignant | Ewing Sarcoma | Diaphysis, long bones | 5-20 |
| Intermediate/Malignant | Giant Cell Tumour | Epiphysis, distal femur/prox. tibia | 20-50 |
| Notochordal | Malignant | Chordoma | Skull base, sacrum | >40 |
| Tumour-like lesions | Benign | Aneurysmal Bone Cyst | Long bones, vertebrae | <30 |
| Benign | Simple (Unicameral) Bone Cyst | Proximal humerus/femur | 5-15 |
3. Descriptive Profiles of Key Tumours
A. OSTEOSARCOMA (Most common primary malignant bone tumour)
| Feature | Details |
|---|
| Epidemiology | Most common primary malignant bone tumour (excluding haematopoietic). Male:Female = 1.6:1. Bimodal age: ~75% under 20 yrs; second peak in elderly (Paget disease, radiation) |
| Location | Metaphysis of long bones; ~50% near the knee (distal femur / proximal tibia) |
| Clinical features | Painful, progressively enlarging mass; pathologic fracture may be first sign |
| Radiology | Large, destructive mixed lytic-and-sclerotic mass with infiltrative margins; periosteum lifted → Codman triangle (triangular reactive subperiosteal bone) |
| Pathogenesis | Mutations in RB (up to 70%), TP53, MDM2, CDK4. Complex karyotype |
| Histology | Malignant osteoblasts producing osteoid matrix; woven bone formation |
| Treatment | Neoadjuvant chemotherapy + surgical limb salvage/amputation + adjuvant chemo |
| Prognosis | ~60-70% 5-year survival with modern chemotherapy |
X-Ray - Distal Femur Osteosarcoma (Codman Triangle):
Distal femur osteosarcoma with bone formation extending into soft tissue. Arrow marks the Codman triangle. - Robbins Pathology Fig. 19.15
Histology - Osteosarcoma:
Osteoid osteoma: anastomosing trabeculae of woven bone rimmed by osteoblasts in fibrovascular stroma. - Robbins Pathology Fig. 19.14
B. CHONDROSARCOMA
| Feature | Details |
|---|
| Epidemiology | 2nd most common primary malignant bone tumour; peak 40-60 years |
| Location | Pelvis, proximal femur, shoulder girdle, ribs |
| Clinical features | Painful enlarging mass; slow growth over years |
| Radiology | Destructive lytic lesion with endosteal scalloping; "rings and arcs" calcification pattern |
| Histology | Hyaline cartilage nodules permeating medullary cavity and cortex; increased cellularity and atypia |
| Grading | Grade 1 (low-grade/ACT) to Grade 3 (high-grade) |
| Treatment | Wide surgical excision; chemotherapy not generally effective |
| Prognosis | Depends on grade: ~90% 5-yr survival (Grade 1) vs <30% (Grade 3) |
Histology - Chondrosarcoma:
Chondrosarcoma: (A) nodules of hyaline cartilage in medullary cavity of sternum growing through cortex into soft tissue; (B) tumour permeating through preexisting trabecular bone. - Robbins Pathology Fig. 19.22
C. EWING SARCOMA
| Feature | Details |
|---|
| Epidemiology | 2nd most common malignant bone tumour in children/adolescents; peak 5-20 years |
| Location | Diaphysis of long bones (femur most common); also pelvis, ribs |
| Clinical features | Painful, tender, warm, swollen affected site; may mimic osteomyelitis |
| Radiology | Destructive lytic tumour with permeative margins; "onion-skin" periosteal reaction |
| Genetics | Characteristic t(11;22) translocation → EWSR1-FLI1 fusion gene |
| Histology | Sheets of small, round, blue cells with minimal cytoplasm |
| Treatment | Neoadjuvant chemotherapy + surgical excision ± radiation |
| Prognosis | ~75% 5-year survival; ~50% long-term cure with modern treatment |
Histology - Ewing Sarcoma:
Ewing sarcoma: sheets of small round cells with minimal clear cytoplasm. - Robbins Pathology Fig. 19.23
D. GIANT CELL TUMOUR (GCT)
| Feature | Details |
|---|
| Epidemiology | 3rd-5th decades; slight female predominance |
| Behaviour | Benign but locally aggressive; rare metastasis (~2%) |
| Location | EPIPHYSIS of long bones - distal femur and proximal tibia (near knee is classic); extends to subchondral bone |
| Clinical features | Joint pain, swelling, occasionally pathologic fracture; arthritis-like symptoms |
| Radiology | Lytic "soap bubble" lesion in epiphysis; destroys cortex; thin shell of reactive bone |
| Pathogenesis | Neoplastic osteoblast precursors express high RANKL → drives osteoclast proliferation → bone destruction |
| Histology | Multinucleate osteoclast-type giant cells (up to 100 nuclei) + uniform oval mononuclear neoplastic cells |
| Treatment | Curettage ± cementation; denosumab (anti-RANKL) for unresectable disease |
| Prognosis | 40% local recurrence after curettage; rarely metastasizes to lung |
E. OSTEOID OSTEOMA & OSTEOBLASTOMA
| Feature | Osteoid Osteoma | Osteoblastoma |
|---|
| Size | < 2 cm | > 2 cm |
| Age | 10-20 yrs, young men | 10-20 yrs |
| Location | Cortex of femur/tibia (50%) | Posterior elements of vertebrae |
| Pain | Severe, worse at night; relieved by NSAIDs (prostaglandin E2-mediated) | Similar but less responsive to NSAIDs |
| Radiology | Round lucent nidus with sclerotic rim | Expansile lytic lesion |
| Treatment | NSAIDs / radiofrequency ablation / excision | Surgical excision |
F. ENCHONDROMA
| Feature | Details |
|---|
| Location | Most common bone tumour of the hand; proximal/middle phalanges, metacarpals |
| Epidemiology | Peak in 2nd decade; equal sex distribution |
| Presentation | Often incidental; lytic lesion on plain X-ray; pain/fracture if large |
| Histology | Fragments of cartilage nests within intramedullary cavity |
| Special syndromes | Multiple enchondromatosis = Ollier disease; with hemangiomas = Maffucci syndrome (malignant transformation risk) |
| Treatment | Curettage + bone grafting if structural integrity compromised |
G. OSTEOCHONDROMA
| Feature | Details |
|---|
| Epidemiology | Most common benign bone tumour overall; 10-30 years |
| Nature | Bony excrescence (exostosis) with a cartilage cap growing outward from bone surface |
| Location | Metaphysis of long bones (distal femur, proximal tibia, proximal humerus) |
| Presentation | Often asymptomatic; found incidentally; rarely malignant transformation (<1% solitary; higher in multiple hereditary exostoses) |
| Treatment | Excision if symptomatic or rapid growth |
H. MULTIPLE MYELOMA
| Feature | Details |
|---|
| Nature | Most common primary malignancy of bone in adults |
| Age | > 60 years |
| Presentation | Back pain; ESR > 100 mm/h is highly suggestive |
| Radiology | "Punched-out" lytic lesions on skull X-ray; diffuse osteopenia |
| Diagnosis | Monoclonal gammopathy; elevated urinary/serum Bence Jones proteins |
| Treatment | Chemotherapy (bortezomib-based regimens), stem cell transplant, bisphosphonates |
4. Comparison Chart: Benign vs Malignant Bone Tumours
| Feature | Benign | Malignant |
|---|
| Border | Well-defined, sclerotic margin | Ill-defined, permeative, moth-eaten |
| Growth rate | Slow | Rapid |
| Cortex | Intact or expanded | Destroyed/breached |
| Periosteal reaction | None or smooth | Aggressive (Codman triangle, onion-skin, sunburst) |
| Soft tissue mass | Absent | Common |
| Matrix | Dense, organised | Irregular, amorphous |
| Metastasis | No | Yes (lung most common) |
| Recurrence | Low | High |
| Systemic symptoms | Absent | Common (weight loss, fever, anaemia) |
5. Diagnostic Approach (3-Phase Protocol)
From Bailey and Love's Short Practice of Surgery 28th Ed:
| Phase 1 (within 24 hrs) | Phase 2 (within 1 week) | Phase 3 (specialist centre) |
|---|
| Full history & examination | Bone scan | CT scan of lesion |
| Blood tests (FBC, ESR, CRP, LFT, ALP, Ca²⁺, PO₄, PSA) | Ultrasound abdomen | MRI of lesion |
| Plain X-ray of whole bone | CT chest (metastasis staging) | Biopsy (gold standard) |
| Chest X-ray | | Bone marrow biopsy (if myeloma suspected) |
Key Clinical Clues:
- Night pain in adolescent + NSAID relief → Osteoid osteoma
- Adolescent + metaphysis + Codman triangle → Osteosarcoma
- Child + diaphysis + onion-skin periosteum → Ewing sarcoma
- Adult 40-60 yrs + pelvis → Chondrosarcoma
- Adult >65 yrs + back pain + ESR >100 → Multiple myeloma
- Epiphysis near knee in 3rd-5th decade → Giant cell tumour
6. Periosteal Reaction Patterns in Bone Tumours
| Pattern | Description | Associated Tumour |
|---|
| Codman triangle | Periosteum lifted at edges, triangular reactive bone | Osteosarcoma |
| Onion-skin (laminated) | Concentric layers of reactive bone | Ewing sarcoma |
| Sunburst/spiculated | Radiating bone spicules perpendicular to cortex | Osteosarcoma |
| Eggshell | Thin expanded cortical shell | Aneurysmal bone cyst, GCT |
| Buttressing | Solid shell at edges | Slow-growing benign lesions |
7. Treatment Summary Chart
| Tumour | Surgery | Chemotherapy | Radiotherapy |
|---|
| Osteosarcoma | Limb salvage / amputation | Yes (neoadjuvant + adjuvant) | Poor response |
| Chondrosarcoma | Wide excision | Not effective | Not effective |
| Ewing Sarcoma | Excision | Yes (neoadjuvant + adjuvant) | Yes (local control) |
| Giant Cell Tumour | Curettage ± cement | Denosumab (unresectable) | Rarely |
| Osteoid Osteoma | RFA / excision | No | No |
| Multiple Myeloma | Supportive (vertebroplasty) | Yes (bortezomib-based) | Yes (palliative) |
| Osteochondroma | Excision if symptomatic | No | No |
| Enchondroma | Curettage + bone graft | No | No |
Sources:
- Robbins & Kumar Basic Pathology, Table 19.1 and Chapter 19
- Grainger & Allison's Diagnostic Radiology - General Characteristics of Bone Tumours, WHO 2013 Classification
- Bailey and Love's Short Practice of Surgery 28th Ed, Chapter 42 - Evaluation of Bone Tumours
- Sabiston Textbook of Surgery, Chapter 119 - Bone Tumors of the Hand
- Campbell's Operative Orthopaedics 15th Ed 2026